Published in Hum Immunol on October 01, 2003
International network of cancer genome projects. Nature (2010) 20.35
Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet (2009) 16.53
A human genome diversity cell line panel. Science (2002) 14.11
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature (2011) 13.23
Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature (2003) 13.00
Prepublication data sharing. Nature (2009) 12.24
A human phenome-interactome network of protein complexes implicated in genetic disorders. Nat Biotechnol (2007) 9.90
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet (2013) 4.62
Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis. Nat Genet (2007) 4.22
Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci. Nat Genet (2013) 2.87
Type 1 diabetes: evidence for susceptibility loci from four genome-wide linkage scans in 1,435 multiplex families. Diabetes (2005) 2.85
Biobanking for Europe. Brief Bioinform (2007) 2.76
Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus. Nat Genet (2010) 2.61
Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor. N Engl J Med (2007) 2.56
A human type 1 diabetes susceptibility locus maps to chromosome 21q22.3. Diabetes (2008) 2.51
Phylogeography of Y-chromosome haplogroup I reveals distinct domains of prehistoric gene flow in europe. Am J Hum Genet (2004) 2.32
The role of a bioresource research impact factor as an incentive to share human bioresources. Nat Genet (2011) 2.27
Smoking and two human leukocyte antigen genes interact to increase the risk for multiple sclerosis. Brain (2011) 2.24
Planning the human variome project: the Spain report. Hum Mutat (2009) 2.22
The Type 1 Diabetes Genetics Consortium. Ann N Y Acad Sci (2006) 2.22
Assessing the impact of biobanks. Nat Genet (2003) 2.18
SLC9A6 mutations cause X-linked mental retardation, microcephaly, epilepsy, and ataxia, a phenotype mimicking Angelman syndrome. Am J Hum Genet (2008) 2.16
Mutations in the insulin gene can cause MODY and autoantibody-negative type 1 diabetes. Diabetes (2008) 2.15
Research priorities. ELSI 2.0 for genomics and society. Science (2012) 2.10
Genome-wide scan for linkage to type 1 diabetes in 2,496 multiplex families from the Type 1 Diabetes Genetics Consortium. Diabetes (2009) 2.02
Remapping the insulin gene/IDDM2 locus in type 1 diabetes. Diabetes (2004) 2.02
Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry. J Clin Endocrinol Metab (2009) 2.01
Whole-genome sequencing in health care: recommendations of the European Society of Human Genetics. Eur J Hum Genet (2013) 1.93
Genetic effects on age-dependent onset and islet cell autoantibody markers in type 1 diabetes. Diabetes (2002) 1.89
An empirical survey on biobanking of human genetic material and data in six EU countries. Eur J Hum Genet (2003) 1.85
Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy. PLoS Genet (2011) 1.80
Genetics of type 1 diabetes: what's next? Diabetes (2010) 1.80
Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms. Hepatology (2008) 1.79
Systems medicine and integrated care to combat chronic noncommunicable diseases. Genome Med (2011) 1.78
Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis. Ann Neurol (2009) 1.76
Genome-wide association analysis in primary sclerosing cholangitis. Gastroenterology (2009) 1.69
Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis. Am J Gastroenterol (2006) 1.68
Genomic incidental findings: reducing the burden to be fair. Am J Bioeth (2013) 1.65
HLA associated genetic predisposition to autoimmune diseases: Genes involved and possible mechanisms. Transpl Immunol (2005) 1.64
Comprehensive catalog of European biobanks. Nat Biotechnol (2011) 1.64
Changes to anti-JCV antibody levels in a Swedish national MS cohort. J Neurol Neurosurg Psychiatry (2013) 1.63
Low serum levels of vitamin D in idiopathic inflammatory myopathies. Ann Rheum Dis (2012) 1.59
Tracing biological collections: between books and clinical trials. JAMA (2008) 1.58
Variation in antiviral 2',5'-oligoadenylate synthetase (2'5'AS) enzyme activity is controlled by a single-nucleotide polymorphism at a splice-acceptor site in the OAS1 gene. Am J Hum Genet (2005) 1.57
Genetic testing and common disorders in a public health framework: how to assess relevance and possibilities. Background Document to the ESHG recommendations on genetic testing and common disorders. Eur J Hum Genet (2011) 1.57
Stromelysin 1 (matrix metalloproteinase 3) and HLA-DRB1 gene polymorphisms: Association with severity and progression of rheumatoid arthritis in a prospective study. Arthritis Rheum (2002) 1.57
OAS1 splice site polymorphism controlling antiviral enzyme activity influences susceptibility to type 1 diabetes. Diabetes (2005) 1.57
Interaction between adolescent obesity and HLA risk genes in the etiology of multiple sclerosis. Neurology (2014) 1.54
Polymorphisms in CLEC16A and CIITA at 16p13 are associated with primary adrenal insufficiency. J Clin Endocrinol Metab (2008) 1.51
Electrostatic modifications of the human leukocyte antigen-DR P9 peptide-binding pocket and susceptibility to primary sclerosing cholangitis. Hepatology (2011) 1.51
Comparative high-resolution analysis of linkage disequilibrium and tag single nucleotide polymorphisms between populations in the vitamin D receptor gene. Hum Mol Genet (2004) 1.48
Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course. Mult Scler (2010) 1.46
Tests for genetic interactions in type 1 diabetes: linkage and stratification analyses of 4,422 affected sib-pairs. Diabetes (2011) 1.44
Collagenase-1 (MMP-1) and HLA-DRB1 gene polymorphisms in rheumatoid arthritis: a prospective longitudinal study. J Rheumatol (2002) 1.43
Lack of replication of interaction between EBNA1 IgG and smoking in risk for multiple sclerosis. Neurology (2012) 1.42
Analysis of MAdCAM-1 and ICAM-1 polymorphisms in 365 Scandinavian patients with primary sclerosing cholangitis. J Hepatol (2006) 1.42
Childhood lung function and the association with β2-adrenergic receptor haplotypes. Acta Paediatr (2013) 1.41
Developing a policy for paediatric biobanks: principles for good practice. Eur J Hum Genet (2012) 1.39
Celiac disease genetics: current concepts and practical applications. Clin Gastroenterol Hepatol (2005) 1.37
LYP inhibits T-cell activation when dissociated from CSK. Nat Chem Biol (2012) 1.37
DNA methylation and gene expression changes in monozygotic twins discordant for psoriasis: identification of epigenetically dysregulated genes. PLoS Genet (2012) 1.35
Association analysis of the interleukin 17A gene in Caucasian rheumatoid arthritis patients from Norway and New Zealand. Rheumatology (Oxford) (2009) 1.34
Practical guidelines addressing ethical issues pertaining to the curation of human locus-specific variation databases (LSDBs). Hum Mutat (2010) 1.33
Whole-genome sequencing in health care. Recommendations of the European Society of Human Genetics. Eur J Hum Genet (2013) 1.31
Integrative analysis for finding genes and networks involved in diabetes and other complex diseases. Genome Biol (2007) 1.27
Recombinant Fabs of human monoclonal antibodies specific to the middle epitope of GAD65 inhibit type 1 diabetes-specific GAD65Abs. Diabetes (2003) 1.23
Quantifying the use of bioresources for promoting their sharing in scientific research. Gigascience (2013) 1.22
Several genes in the extended human MHC contribute to predisposition to autoimmune diseases. Curr Opin Immunol (2005) 1.19
TiSH--a robust and sensitive global phosphoproteomics strategy employing a combination of TiO2, SIMAC, and HILIC. J Proteomics (2012) 1.19
Risk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08. Ann Neurol (2012) 1.19
The PTPN22 R263Q polymorphism is a risk factor for rheumatoid arthritis in Caucasian case-control samples. Arthritis Rheum (2011) 1.18
Polymorphisms in the cytotoxic T lymphocyte antigen-4 gene region confer susceptibility to Addison's disease. J Clin Endocrinol Metab (2004) 1.17
A new classification of HLA-DRB1 alleles differentiates predisposing and protective alleles for rheumatoid arthritis structural severity. Arthritis Rheum (2006) 1.17
Circulating levels of microRNA from children with newly diagnosed type 1 diabetes and healthy controls: evidence that miR-25 associates to residual beta-cell function and glycaemic control during disease progression. Exp Diabetes Res (2012) 1.17
New classification of HLA-DRB1 alleles in rheumatoid arthritis susceptibility: a combined analysis of worldwide samples. Arthritis Res Ther (2008) 1.17
Lack of support for association between the KIF1B rs10492972[C] variant and multiple sclerosis. Nat Genet (2010) 1.16
Genetics of diabetes--are we missing the genes or the disease? Mol Cell Endocrinol (2013) 1.16
The lack of anti-idiotypic antibodies, not the presence of the corresponding autoantibodies to glutamate decarboxylase, defines type 1 diabetes. Proc Natl Acad Sci U S A (2008) 1.15
Increased risk of childhood type 1 diabetes in children born after 1985. Diabetes Care (2002) 1.14
Mapping the translational science policy 'valley of death'. Clin Transl Med (2013) 1.13
Heredity of hypospadias and the significance of low birth weight. J Urol (2002) 1.12
Linkage disequilibrium organization of the human KIR superlocus: implications for KIR data analyses. Immunogenetics (2010) 1.12
Activating transcription factor 3: a hormone responsive gene in the etiology of hypospadias. Eur J Endocrinol (2008) 1.12
Immunogenetics as a tool in anthropological studies. Immunology (2011) 1.11
Mutation screening of PTPN22: association of the 1858T-allele with Addison's disease. Eur J Hum Genet (2008) 1.10
Limitations and possibilities of low cell number ChIP-seq. BMC Genomics (2012) 1.09